Liminatus Pharma, Inc. LIMN
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-05-18
Liminatus Pharma, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 677,518 | $116,465 | 2.5% |
| D. E. Shaw & Co., Inc. | 83,353 | $3,334 | 0.31% |
| MILLENNIUM MANAGEMENT LLC | 70,616 | $2,825 | 0.26% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.